Biotech Experiences Strong Open Following Major Announcement
2024年7月10日 - 11:35PM
AllPennyStocks.com
An Australian biotech company is already
turning heads so far on Wednesday after it was announced results
from its GBM-AGILE, which is a phase II/III study that included
an...
To read the full story on AllPennyStocks.com, click
here.
Kazia Therapeutics (NASDAQ:KZIA)
過去 株価チャート
から 6 2024 まで 7 2024
Kazia Therapeutics (NASDAQ:KZIA)
過去 株価チャート
から 7 2023 まで 7 2024